Research ArticleHuman Studies
Validation of Gallium-67-Citrate Single-Photon Emission Computed Tomography in Biopsy-Confirmed Residual Hodgkin's Disease in the Mediastinum
Lale Kostakoglu, Samuel D.J. Yeh, Carol Portlock, Robert Heelan, Tzy-Jyun Yao, Donna Niedzwiecki and Steven M. Larson
Journal of Nuclear Medicine March 1992, 33 (3) 345-350;
Lale Kostakoglu
Samuel D.J. Yeh
Carol Portlock
Robert Heelan
Tzy-Jyun Yao
Donna Niedzwiecki


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Validation of Gallium-67-Citrate Single-Photon Emission Computed Tomography in Biopsy-Confirmed Residual Hodgkin's Disease in the Mediastinum
Lale Kostakoglu, Samuel D.J. Yeh, Carol Portlock, Robert Heelan, Tzy-Jyun Yao, Donna Niedzwiecki, Steven M. Larson
Journal of Nuclear Medicine Mar 1992, 33 (3) 345-350;
Validation of Gallium-67-Citrate Single-Photon Emission Computed Tomography in Biopsy-Confirmed Residual Hodgkin's Disease in the Mediastinum
Lale Kostakoglu, Samuel D.J. Yeh, Carol Portlock, Robert Heelan, Tzy-Jyun Yao, Donna Niedzwiecki, Steven M. Larson
Journal of Nuclear Medicine Mar 1992, 33 (3) 345-350;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
- Whole-Body Positron Emission Tomography Using 18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin's Disease and Non-Hodgkin's Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging